A Phase 1, Single Dose Pk And Safety Study With Ni-03 Followed By A Phase 2, Randomized, Double-Blind, Parallel-Group Dose-Ranging Study To Evaluate The Safety And Efficacy Of Ni-03 Compared To Placebo In Subjects With Chronic Pancreatitis
The purpose of this study is to determine the safety and efficacy of NI-03.
Available at the following location(s)
Do you need help with some of the labels on this page?
Read our glossary of terms